Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide. the EMN011 Trial

被引：20

作者：

Sonneveld, Pieter ^{[1
]}

Zweegman, Sonja ^{[2
]}

Cavo, Michele ^{[3
]}

Nasserinejad, Kazem ^{[4
]}

Troia, Rosella ^{[5
]}

Pour, Ludek ^{[6
]}

Croockewit, Sandra ^{[7
]}

Corradini, Paolo ^{[8
,9
]}

Patriarca, Francesca ^{[10
]}

Wu, Kalung ^{[11
]}

Droogendijk, Jolanda ^{[12
]}

Broyl, Annemiek ^{[1
]}

Minnema, Monique C. ^{[13
]}

Costa, Bruno ^{[14
]}

Iskander, Karim Saad ^{[15
]}

Boccadoro, Mario ^{[16
]}

机构：

[1] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[2] Univ Amsterdam, Med Ctr, Canc Canc Amsterdam, Dept Hematol, Amsterdam, Netherlands

[3] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[4] Erasmus MC Canc Inst, Rotterdam, Netherlands

[5] Univ Torino, Hematol, Turin, Italy

[6] Univ Hosp, Hematol, Brno, Czech Republic

[7] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands

[8] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Hematol Div, Milan, Italy

[9] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Hematooncol Dept, Milan, Italy

[10] Univ Udine, Hematol & Bone Marrow Transplant Unit, Udine, Italy

[11] Zna Stuivenberg, Hematol, Antwerp, Belgium

[12] Tweesteden Ziekenhuis, Hematol, Tilburg, Netherlands

[13] Univ Utrecht, UMC Utrecht Canc Ctr, Dept Hematol, Utrecht, Netherlands

[14] Celgene Int, Boudry, Switzerland

[15] Amgen Inc, Thousand Oaks, CA 91320 USA

[16] Univ Torino, Hematol Div, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-114029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

801

引用

页数：3

共 50 条

[1] Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with First Progression of Multiple Myeloma Refractory to Bortezomib and Lenalidomide. Final Report of the EMN011/HOVON114 Trial
Sonneveld, Pieter
Zweegman, Sonja
Cavo, Michele
Nasserinejad, Kazem
Broyl, Annemiek
Troia, Rosella
Pour, Ludek
Croockewit, Sandra
Corradini, Paolo
Bos, Gerard M. J.
Wu, Ka Lung
Droogendijk, Jolanda
Minnema, Monique C.
Boccadoro, Mario
BLOOD, 2021, 138
[2] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Paludo, Jonas
Mikhael, Joseph R.
LaPlant, Betsy R.
Halvorson, Alese E.
Kumar, Shaji
Gertz, Morie A.
Hayman, Suzanne R.
Buadi, Francis K.
Dispenzieri, Angela
Lust, John A.
Kapoor, Prashant
Leung, Nelson
Russell, Stephen J.
Dingli, David
Go, Ronald S.
Lin, Yi
Gonsalves, Wilson I.
Fonseca, Rafael
Bergsagel, P. Leif
Roy, Vivek
Sher, Taimur
Chanan-Khan, Asher A.
Ailawadhi, Sikander
Stewart, A. Keith
Reeder, Craig B.
Richardson, Paul G.
Rajkumar, S. Vincent
Lacy, Martha Q.
BLOOD, 2017, 130 (10) : 1198 - 1204
[3] Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed Lenalidomide Refractory Multiple Myeloma (MM)
Lacy, Martha Q.
LaPlant, Betsy R.
Laumann, Kristina M.
Kumar, Shaji
Gertz, Morie A.
Hayman, Suzanne R.
Buadi, Francis
Dispenzieri, Angela
Lust, John A.
Kapoor, Prashant
Leung, Nelson
Russell, Stephen J.
Dingli, David
Gonsalves, Wilson I.
Fonseca, Rafael
Bergsagel, P. Leif
Roy, Vivek
Sher, Taimur
Ailawadhi, Sikander
Chanan-Khan, Asher
Stewart, A. Keith
Reeder, Craig B.
Rajkumar, S. Vincent
Mikhael, Joseph R.
BLOOD, 2014, 124 (21)
[4] Carfilzomib-Pomalidomide-Dexamethasone (KPD) in Relapsed/Refractory Multiple Myeloma Patients - an Institutional Retrospective Analysis
Mehta, Pallavi
Yadav, Neha
Bhaarat, Mohan
Mirgh, Sumeet Prakash
Khushoo, Vishvdeep
Thekuddan, Shinto Francis
Agrawal, Narendra
Ahmed, Rayaz
Bhurani, Dinesh
BLOOD, 2019, 134
[5] The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide
Wang, Tzu-Fei
Fiala, Mark
Ahluwalia, Rohan
Trinkaus, Kathryn
Moliske, Caitlin
Cox, Doug
Jaenicke, Matthew
Stockerl-Goldstein, Keith
Wildes, Tanya
Carson, Kenneth R.
Tomasson, Michael H.
Vij, Ravi
BLOOD, 2012, 120 (21)
[6] The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Wang, Tzu-Fei
Ahluwalia, Rohan
Fiala, Mark A.
Trinkaus, Kathryn M.
Cox, Doug P.
Jaenicke, Matthew
Moliske, Caitlin C.
Carson, Kenneth R.
Wildes, Tanya M.
Tomasson, Michael H.
Stockerl-Goldstein, Keith E.
Vij, Ravi
LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 337 - 341
[7] Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study
Jasielec, Jagoda
Zonder, Jeff
Derman, Benjamin A.
Reece, Donna E.
Cole, Craig E.
Berdeja, Jesus G.
Wolfe, Brittany
Major, Sarah
Tinari, Kathryn M.
Stefka, Andrew
Fazzi, Fabrizio
Whelan, Megan
Gleason, Christine
McIver, Amanda
Andreatos, Evangelia
Libao, Bernadette M.
Juergens, Daniel
Griffith, Kent
Jakubowiak, Andrzej
BLOOD, 2020, 136
[8] Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Sonneveld, Pieter
Zweegman, Sonja
Cavo, Michele
Nasserinejad, Kazem
Broijl, Annemiek
Troia, Rosella
Pour, Ludek
Croockewit, Sandra
Corradini, Paolo
Patriarca, Francesca
Wu, Kalung
Droogendijk, Jolanda
Bos, Gerard
Hajek, Roman
Teresa Petrucci, Maria
Ypma, Paula
Zojer, Nicholas
Minnema, Monique C.
Boccadoro, Mario
HEMASPHERE, 2022, 6 (10): : E786
[9] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Ri, M.
Suzuki, K.
Chou, T.
Sugiura, I.
Takezako, N.
Sunami, K.
Ishida, T.
Izumi, T.
Ozaki, S.
Iida, S.
HAEMATOLOGICA, 2016, 101 : 787 - 788
[10] A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma
Mikhael, Joseph R.
Roy, Vivek
Richardson, Paul G.
Jakubowiak, Andrzej
Laumann, Kristina
LaPlant, Betsy R.
Dispenzieri, Angela
Rajkumar, S. Vincent
Fonseca, Rafael
Leung, Nelson
Buadi, Francis
Bergsagel, Leif
Kyle, Robert
Witzig, Thomas E.
Reeder, Craig
Lust, John A.
Russell, Stephen
Hayman, Suzanne R.
Kumar, Shaji K.
Dingli, David
Ansell, Stephen M.
Dalton, Robert
Lin, Yi
Sher, Taimur
Kapoor, Prashant
McCurdy, Arleigh
Chanan-Khan, Asher
Stewart, A. Keith
Gertz, Morie A.
Lacy, Martha Q.
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →